CD274 and inflammatory breast carcinoma: In a multivariate logistic regression model, using sTIL infiltration and molecular subtype as possible confounders, patients with IBC also showed significantly more PD-L1+ immune cells (OR 2.43, 95%CI 1.19–5.04, P = 0.01) compared to nIBC patients.